UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)

Haematologica (Roma), 2014-01, Vol.99 (1), p.111

2014

Volltextzugriff (PDF)

Export and exports risks of small and medium enterprises during the COVID-19 pandemic

Problems and perspectives in management, 2023, Vol.21 (1), p.24-34

2023

Volltextzugriff (PDF)

Effect of crises on human resources management in small and medium enterprises: Evidence from manufacturing industry in the Czech Republic

Problems and perspectives in management, 2022-04, Vol.20 (2), p.10-21

2022

Volltextzugriff (PDF)

Competitiveness of the Regions in the Czech Republic from the Perspective of Disaster Risk Financing

Journal of competitiveness, 2021-12, Vol.13 (4), p.115-131

2021

Volltextzugriff (PDF)

Human Resources Management in the Corporate Crisis

Chemical engineering transactions, 2020-10, Vol.82

2020

Volltextzugriff (PDF)

Means of Transporting Counterfeits to the European Union

Chemical engineering transactions, 2020-10, Vol.82

2020

Volltextzugriff (PDF)

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101

Journal of clinical oncology, 2010-10, Vol.28 (29), p.4500-4506

2010

Volltextzugriff (PDF)

The personal crisis in the selected hospital and impact to the safety

MATEC Web of Conferences, 2019, Vol.292, p.1046

2019

Volltextzugriff (PDF)

International trade risks

MATEC Web of Conferences, 2019, Vol.292, p.1047

2019

Volltextzugriff (PDF)

Possibilities of security measures in museums in the czech republic

MATEC Web of Conferences, 2018, Vol.210, p.3010

2018

Volltextzugriff (PDF)

Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4290-4301

2004

Volltextzugriff (PDF)

Economic Impacts of the Covid-19 Pandemic on the National Economy of the Czech Republic

Chemical engineering transactions, 2022-06, Vol.91

2022

Volltextzugriff (PDF)

Autologous Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Achieves Outcomes Similar to Allogeneic Transplantation - Results of CALGB 10001 (Alliance)

Blood, 2012-11, Vol.120 (21), p.816-816

2012

Volltextzugriff (PDF)

Risk Management in Health Care Organizations in the Czech Republic

Chemical engineering transactions, 2021-06, Vol.86

2021

Volltextzugriff (PDF)

Quality Management Systems in Selected Public Organizations

Chemical engineering transactions, 2021-06, Vol.86

2021

Volltextzugriff (PDF)

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)

Leukemia, 2017-01, Vol.31 (1), p.34-39

2017

Volltextzugriff (PDF)

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: Cancer and Leukemia Group B study 10002

British journal of haematology, 2014-04, Vol.165 (1), p.102-111

2014

Volltextzugriff (PDF)

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002

British journal of haematology, 2014-04, Vol.165 (1), p.102-111

2014

Volltextzugriff (PDF)

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)

Blood, 2003-01, Vol.101 (1), p.6-14

2003

Volltextzugriff (PDF)

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Blood, 2010-09, Vol.116 (9), p.1413-1421

2010

Volltextzugriff (PDF)

Alliance A061202. a Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib Versus Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Refractory to Lenalidomide and Proteasome Inhibitor Based Therapy: Phase I Results

Blood, 2015-12, Vol.126 (23), p.375-375

2015

Volltextzugriff (PDF)

Recombinant interleukin‐2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808

Cancer, 2014-04, Vol.120 (7), p.1010-1017

2014

Volltextzugriff (PDF)

CALGB 100801 (Alliance): A Phase II Multi-Center NCI Cooperative Group Study of the Addition of Azacitidine (AZA) to Reduced-Intensity Conditioning (RIC) Allogeneic Transplantation for High Risk Myelodysplasia (MDS) and Older Patients with Acute Myeloid Leukemia (AML): Results of a “test dose” Strategy to Target Busulfan Exposure

Blood, 2014-12, Vol.124 (21), p.543-543

2014

Volltextzugriff (PDF)

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Blood advances, 2018-07, Vol.2 (14), p.1705-1718

2018

Volltextzugriff (PDF)

Maintenance Therapy with Decitabine in Younger Adults with Acute Myeloid Leukemia (AML) in First Remission: A Phase II Cancer and Leukemia Group B Study (CALGB 10503, Alliance)

Blood, 2012-11, Vol.120 (21), p.44-44

2012

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(23)
Male
(16)
Humans
(15)
Female
(14)
Middle Aged
(10)
Adult
(8)
Biological And Medical Sciences
(7)
Hematology
(7)
Treatment Outcome
(7)
Animals
(6)
Medical Sciences
(6)
Aged
(5)
Environmental Sciences & Ecology
(5)
Hematologic And Hematopoietic Diseases
(5)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(5)
Poecilia Reticulata
(5)
Predation
(5)
Survival Rate
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)

Export and exports risks of small and medium enterprises during the COVID-19 pandemic

Effect of crises on human resources management in small and medium enterprises: Evidence from manufacturing industry in the Czech Republic

Competitiveness of the Regions in the Czech Republic from the Perspective of Disaster Risk Financing

Human Resources Management in the Corporate Crisis

Means of Transporting Counterfeits to the European Union

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101

The personal crisis in the selected hospital and impact to the safety

International trade risks

Possibilities of security measures in museums in the czech republic

Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621

Economic Impacts of the Covid-19 Pandemic on the National Economy of the Czech Republic

Autologous Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Achieves Outcomes Similar to Allogeneic Transplantation - Results of CALGB 10001 (Alliance)

Risk Management in Health Care Organizations in the Czech Republic

Quality Management Systems in Selected Public Organizations

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: Cancer and Leukemia Group B study 10002

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Alliance A061202. a Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib Versus Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Refractory to Lenalidomide and Proteasome Inhibitor Based Therapy: Phase I Results

Recombinant interleukin‐2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Maintenance Therapy with Decitabine in Younger Adults with Acute Myeloid Leukemia (AML) in First Remission: A Phase II Cancer and Leukemia Group B Study (CALGB 10503, Alliance)

Suchergebnisse filtern